Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.67 |
| ▸ | CALCR | P30988 | 4/20 | 0.58 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.53 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.53 |
| ▸ | NMBR | P28336 | 1/20 | 0.53 |
| ▸ | GRPR | P30550 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.53 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.53 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.52 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30504145 | 1.00 | F2 (0.67) | F2CALCRCRHR1CRHR2NMBR | |
| SCHEMBL30504153 | 1.00 | F2 (0.67) | F2CALCRCRHR1CRHR2NMBR | |
| SCHEMBL30504132 | 0.95 | F2 (0.62) | F2CALCRNMBRGRPROPRD1 | |
| SCHEMBL30504143 | 0.94 | F2 (0.69) | F2CALCRNMBRGRPRNTSR2 | |
| SCHEMBL31366365 | 0.94 | NMBR (0.61) | F2CALCRNMBRGRPROPRD1 | |
| SCHEMBL30504141 | 0.89 | NTSR1 (0.57) | SLC6A2OPRD1NTSR2NTSR1 | |
| SCHEMBL29802631 | 0.87 | SLC6A2 (0.60) | SLC6A2OPRD1OPRM1 | |
| SCHEMBL31182856 | 0.86 | CALCR (0.75) | F2CALCRCRHR1CRHR2HCRTR1 | |
| SCHEMBL31453815 | 0.86 | F2 (0.67) | F2CALCRCRHR1CRHR2NMBR | |
| SCHEMBL31453812 | 0.86 | F2 (0.67) | F2CALCRCRHR1CRHR2NMBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240408167-A1 | COMPOSITION FOR TREATING OCULAR DISEASES CONTAINING PEPTIDE | Encuragen Inc. (KR) | 2024-12-12 | — | — | US | claimed |
| US-20240408167-A1 | COMPOSITION FOR TREATING OCULAR DISEASES CONTAINING PEPTIDE | Encuragen Inc. (KR) | 2024-12-12 | — | — | US | disclosed |
| CN-109689678-B | Agonist peptides for adiponectin receptors | B·B·金 | 2024-04-09 | — | — | CN | disclosed |
| CN-116535469-A | Peptides having adiponectin receptor agonist function and agonists of adiponectin receptor | B·B·金 | 2023-08-04 | — | — | CN | disclosed |